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Ultra-Low-Dose MDCT of the Chest: 
Influence on Automated Lung 
Nodule Detection
Objective: To evaluate the relationship between CT dose and the performance
of a computer-aided diagnosis (CAD) system, and to determine how best to mini-
mize patient exposure to ionizing radiation while maintaining sufficient image
quality for automated lung nodule detection, by the use of lung cancer screening
CT.
Materials and Methods: Twenty-five asymptomatic volunteers participated in
the study. Each volunteer underwent a low-dose CT scan without contrast
enhancement (multidetector CT with 16 detector rows, 1.25 mm section thick-
ness, 120 kVp, beam pitch 1.35, 0.6 second rotation time, with 1.25 mm thick-
ness reconstruction at 1.25 mm intervals) using four different amperages 32, 16,
8, and 4 mAs. All series were analyzed using a commercially available CAD sys-
tem for automatic lung nodule detection and the results were reviewed by a con-
sensus reading by two radiologists. The McNemar test and Kappa analysis were
used to compare differences in terms of the abilities to detect pulmonary nodules.
Results: A total of 78 non-calcified true nodules were visualized in the 25 study
subjects. The sensitivities for nodule detection were as follows: 72% at 32 mAs,
64% at 16 mAs, 59% at 8 mAs, and 40% at 4 mAs. Although the overall nodule-
detecting performance was best at 32 mAs, no significant difference in nodule
detectability was observed between scans at 16 mAs or 8 mAs versus 32 mAs.
However, scans performed at 4 mAs were significantly inferior to those performed
at 32 mAs (p < 0.001).
Conclusion: Reducing the radiation dose (i.e. reducing the amperage) lowers
lung nodule detectability by CAD. However, relatively low dose scans were found
to be acceptable and to cause no significant reduction in nodule detectability ver-
sus usual low-dose CT.
ecently, low-dose CT has been used as a screening and early detection
tool for lung cancer (1 6). Kaneco et al. (6) compared the use of low-
dose spiral CT with radiography for the early detection of small periph-
eral lung cancers in a high-risk population, and found that the use of low-dose spiral
CT is superior to the use of chest radiography. However, Nitta et al. (5) described
many issues concerning lung cancer screening by CT, and concluded that issues such as
economic viability, safety concerns (i.e., radiation dose), and the ability to accommo-
date widespread screening, remain to be resolved.
One of the major concerns of using CT for lung cancer screening is the burden
imposed on radiologists, and this will continue to increase given the continued
adoption of low-dose CT for lung cancer screening. Therefore, a suitable computer-
aided detection (CAD) system is required to assist radiologists during the lung nodule
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Rdetection process, and as a result, many researchers have
advocated the usefulness of CAD systems for lung nodule
detection (7 12).
Another major concern is that even low-dose helical CT
exposes patients to more radiation than in chest radiogra-
phy (5). Although low- to ultra-low-dose chest CT has
been used, conventional 50 mA low-dose CT is normally
used for lung cancer screening (3, 6, 13). Moreover,
previous studies on low-dose or ultra-low-dose CT were
performed without a CAD system (3, 5, 6, 13), and no
comparative information is available in the English
language clinical literature on low-dose and ultra-low-dose
CT supported by a CAD system. In the present study, we
assessed the rationale and feasibility of the use of ultra-
low-dose helical CT using a CAD system. The purpose of
our study was to evaluate the relationship between CT
dose reduction and CAD system detection performance,
and to determine how best to minimize patient exposure
to ionizing radiation while maintaining a sufficient image
quality for automated lung nodule detection during lung
cancer screening by the use of CT.
MATERIALS AND METHODS
The institutional review board approved this prospective
study, and written informed consent was obtained from all
25 study subjects.
Subjects
The study cohort was composed of 25 asymptomatic
volunteers (13 men, 12 women) between the ages of 35
and 77 years (mean age, 62 years). Subjects were divided
by body status into two groups. At first, body mass index
(BMI) was calculated from subject height and weight.
Subjects with a BMI of 25 or more were included in the
obese group and subjects with a BMI of less than 25 were
included into the normal or slender group. The overall
mean BMI was 24.3 kg/m
2 (range, 18.9 29.3 kg/m
2).
There were 11 patients with a BMI of 25 or more; 14
patients had a BMI of less than 25.
Image Acquisition
All CT examinations were performed using a Light
Speed 16 Scanner (General Electric Medical Systems,
Milwaukee, WI). Intravenous contrast medium was not
injected into any subject. Volumetric helical CT scans were
obtained through the thorax using four different tube
currents 32, 16, 8 and 4 mAs per slice in each patient
consecutively and without having the patients leave the
scanner between scans. The entire scanning schedule took
less than 5 minutes per patient. The scanning parameters
used were 120 kVp, 16 1.25 mm detector thickness set,
beam pitch 1.35 and a 0.6 second gantry rotation time.
Transverse images were reconstructed using a 36-cm
display field of view, a 1.25-mm section thickness, and at
1.25-mm intervals using a high spatial frequency (bone)
reconstruction algorithm.
Measurement of Radiation Dose
To determine the actual amount of radiation delivered at
different tube currents, we measured the absorbed
radiation dose. Radiation doses applied to lungs were
obtained from direct thermoluminescence dosimeter
measurements using an anthropomorphic Rando phantom
(model RAN-110, Churchin Associates, Smithtown, NY),
and lithium fluoride chips (TLD-100 [3.2 3.2 0.9 mm
3],
Thermo RMP, Solon, OH). Two lithium fluoride chips were
placed in the center of the phantom lungs along its main
axis, i.e., one in the right and in the left lungs.
Measurements were performed four times at each of the
four tube currents. Organ and tissue doses were assessed
by calculating average absorbed doses.
Image Interpretation and Analysis 
Network transfer of CT data from a picture archiving
and communication system (Centricity 2.0, General
Electric Medical Systems, Milwaukee, WI) to a CAD
workstation was realized using the DICOM protocol.
Images were displayed and were processed using a
commercially available software program (Extended
Brilliance Workspace v 2.0, Philips Medical Systems,
Cleveland, OH). Both mediastinal (window width, 400
Hounsfield units [HU]; window level, 20 HU) and lung
(window width, 1,500 HU; window level,  700 HU)
window images were visualized on workstation monitors.
Two radiologists (a radiology resident and a thoracic
radiologist with 10 years experience) carefully reviewed
four sets of chest CT scans for non-calcified true lung
nodules between 3 and 20 mm in diameter for reference
purposes. The numbers, sizes, and locations of the true
nodules were recorded. Each of the CT scans was then
reviewed using the CAD system, and details of the
candidate lesions were recorded.
The two reviewers evaluated each CT scan and
compared the CAD results, and decided by consensus
whether the pulmonary nodules detected by CAD
represented true or false nodules. The number of true
positive and false positive nodules and their locations were
documented.
Data and Statistical Analysis
The sensitivities and number of false- and true-positive
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current based on the radiologists’ consensus opinions.
However, because true-negative findings could not be
recorded for individual nodules in the lungs, specificities
and negative predictive values could not be calculated.
The McNemar test and Kappa analysis were used to
compare differences in pulmonary nodule detectabilities in
the same lungs at 4, 8, and 16 mAs versus 32 mAs. The
Mann-Whitney test was used to compare the differences in
pulmonary nodule detectabilities between different
locations and different BMI groups. P values of < 0.05
were taken to indicate statistical significance.
RESULTS
Tube Currents and Lesion Detectabilities
Transverse CT scans acquired at the four tube currents
are shown in Figure 1. The image quality expectedly
decreased and noise increased as the tube currents were
reduced. The radiation doses actually delivered at each of
the 4 tube currents are summarized in Table 1, and in
particular, radiation delivered to organs at 8 mAs was less
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Fig. 1. Transverse CT scans were acquired at tube currents of 32 (A), 16 (B), 8 (C), and 4 (D) mAs. Note that image quality was reduced
and noise was increased as tube currents were decreased.
CD
Table 1. Doses Delivered at Different Tube Currents
Tube Currents (mAs/slice) Mean Radiation Dose (mGy)
04 0.76
08 1.52
16 3.04
32 6.09than a quarter of that delivered at 32 mAs.
The total number of nodules detected, including true and
false positive nodules, was 149 nodules at 32 mAs, 138
nodules at 16 mAs, 161 nodules at 8 mAs and 139 nodules
at 4 mAs based on use of the CAD system. Twenty-three
of the 25 patients had nodules seen in the CT scans. A total
of 78 non-calcified true nodules (3.1 per person) were
determined to be true nodules and were used as the
reference standard. The numbers of pulmonary nodules
and the sensitivities of each series of 4 tube currents are
summarized in Table 2. Of these 78 nodules, the CAD
system allowed the reviewers to identify 56 nodules (at 32
mAs), 50 nodules (at 16 mAs), 46 nodules (at 8 mAs) and
31 nodules (at 4 mAs), corresponding to sensitivities of
72%, 64%, 59%, and 40%, respectively. Sensitivity
differences were not significant between 32 mAs and 16
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Fig. 2. Five-mm nodule in right lower lobe superior segment, which was detected at 32 (A), 16 and 8 mAs/slice (not shown in this figure),
but not at 4 mAs/slice (C) on the CAD system. Note that volume-rendering image obtained at 32 mAs (B) is sharper than that obtained at
4 mAs (D).
CDmAs (p = 0.361, k = 0.3624) or between 32 mAs and 8
mAs (p = 0.123, k = 0.2882). Although images acquired at
16 and 8 mAs were less well resolved than those obtained
at 32 mAs, and the overall nodule detection was best at 32
mAs, no statistically significant degradation in nodule
detectability was found at 16 mAs or 8 mAs versus 32
mAs. However, the number of nodules detected were
significantly different at 4 mAs than at 32 mAs (p <
0.0001, k = 0.2666) (Fig. 2). The average number of false-
positive nodules at the individual current setting were 3.7
at 32 mAs, 3.5 at 16 mAs, 4.6 at 8 mAs, and 4.3 at 4 mAs
on a per patient basis. No statistical differences were found
for the average number of false-positive nodules at 16
mAs, 8 mAs, and 4 mAs compared to that for 32 mAs (p
values were 0.685, 0.139 and 0.387, respectively, using
the paired sample t-test).
Nodule Location and Detectability
With regard to the nodule locations, the CAD system
better identified nodules in the lower lobes than in the
upper or middle lobes at all tube currents (Table 3). In
terms of nodule detection in the upper lobes, the sensitivity
rates were 71% (20 of 28) at 32 mAs, 61% (17 of 28) at
16 mAs, 57% (16 of 28) at 8 mAs and 32% (9 of 28) at 4
mAs. In the lower lobes, the sensitivities were 82% (23 of
28) at 32 mAs, 64% (18 of 28) at 16 mAs, 57% (16 of 28)
at 8 mAs and 50% (14 of 28) at 4 mAs. However,
although the detectability of nodules in the lower lobes
was better than in the upper lobes, the difference was not
statistically significant (p = 0.222, Mann-Whitney test).
Body Mass Indices and Detectabilities
With regards to the BMI, the CAD system better identi-
fied nodules in slim patients than in obese patients at all
tube currents (Table 4). For nodules in patients with a BMI
of less than 25, the detection sensitivities were 78% (40 of
51) at 32 mAs, 65% (33 of 51) at 16 mAs, 65% (33 of 51)
at 8 mAs, and 53% (27 of 51) at 4 mAs. In patients with a
BMI over 25, detectabilities were 59% (16 of 27) at 32
mAs, 63% (17 of 27) at 16 mAs, 48% (13 of 27) at 8 mAs,
and 15% (4 of 27) at 4 mAs. Moreover, the lung nodule
detection sensitivity was significantly better in patients
with a BMI of less than 25 (p = 0.001, Mann-Whitney test).
DISCUSSION
The goal of lung cancer screening CT is the detection of
small cancers, presumably when they are at a biologically
early stage. The 5-year survival rate after resection of stage
IA non-small cell lung cancer is 62 82% (14), and the
outcomes of patients who decline treatment for stage I
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Table 2. Detection Performance of CAD System and Actual Doses Delivered
Effective Dose Detected Nodules No. of True Nodules Sensitivity p value No. of False Nodules
32 mAs 149 56 72% 093 (3.7)
16 mAs 138 50 64% 0.361 088 (3.5)
08 mAs 161 46 59% 0.123 115 (4.6)
04 mAs 139 31 40% < 0.001 108 (4.3)
Note. Numbers in parentheses are nodule numbers per case.
Table 3. CAD Detection Rates of Nodules with respect to Nodule Location
Upper Middle Lower All
All number (%) of true nodules 28 22 28 78
32 mAs/slice 20 (71%) 13 (59%) 23 (82%) 56 (72%)
16 mAs/slice 17 (61%) 15 (68%) 18 (64%) 50 (64%)
08 mAs/slice 16 (57%) 14 (64%) 16 (57%) 46 (59%)
04 mAs/slice 09 (32%) 08 (36%) 14 (50%) 31 (40%)
Note. Numbers in parentheses are sensitivities as %.
Table 4. CAD Detection Rates of Nodules versus Patient
BMIs
BMI > 25 BMI  25 All
All number (%) of 
true nodules
27 51 78
32 mAs/slice 16 (59%) 40 (78%) 56 (72%)
16 mAs/slice 17 (63%) 33 (65%) 50 (64%)
08 mAs/slice 13 (48%) 33 (65%) 46 (59%)
04 mAs/slice 04 (15%) 27 (53%) 31 (40%)
Note. CAD = computer-aided diagnosis, BMI = body mass index,
Numbers in parentheses are sensitivities as %. cancer is dismal (15). This is why many investigators in the
medical community are hopeful that CT screening will
provide a means of detecting early stage lung cancer.
During the past few years, low-dose CT has been accepted
to be a highly sensitive modality to use for detecting small
pulmonary nodules (6, 16, 17). Kaneko et al. (6) described
15 cancers that were found during 3,457 routine screening
CT examinations; only four of these cancers were evident
by chest radiography, and 14 were at stage I. Swensen et
al. (16) reported 40 cases of lung cancers in 1,049 CT
examinations, and found that CT alone depicted 36 cases,
whereas a sputum cytological examination alone detected
only two cancers. Henschke and colleagues (17) evaluated
the low-dose CT scans of 1,000 asymptomatic individuals
aged 60 years or more, with a history of at least 10 pack-
years of cigarette smoking, and compared findings with
those of chest radiography. It was found that low-dose CT
markedly better detected small non-calcified nodules, and
better-detected early stage lung cancer. Moreover, low-
dose CT detected three times as many non-calcified
nodules, four times as many malignancies, and six times as
many stage I malignancies than chest radiography.
However, the radiation risk posed by low dose CT is not
negligible. Calculations made by Brenner (22) revealed
that if 50% of all current and former smokers aged 50 75
years in the U.S. received annual CT screening, lung
cancers associated with radiation due to screening would
increase in patients that received the routine screening
chest CT scan by 2%. 
The relationship between radiation exposure and biologi-
cal risk to patients is determined by extrapolation, based
on changes observed after exposure to higher levels of
radiation (18). In addition, patient age and sex should be
considered when analyzing risk; for example, the delivery
of 1 rad (10 mGy) to the breast of a woman younger than
35 years old is estimated to increase the risk of breast
cancer by approximately 14% over the spontaneous rate
in the general population (19).
Tube current reductions cause proportionate reductions
in the delivered radiation dose, as the dosage is linearly
related to amperage at a fixed tube voltage (13, 20, 21).
The radiation dose delivered during routine chest CT scans
using a sixteen-channel multi-detector CT (120 kVp, 150
mAs, 20-mm beam collimation, and 1.67 beam pitch) at
our institution is about 14 mGy, and the radiation dose of
conventional low-dose CT (120 kVp, 33 mAs, 20-mm
collimation, and 1.35 beam pitch) is 6.1 mGy. In contrast,
the radiation dose delivered by ultra-low-dose CT at 8
mAs (120 kVp, 20-mm collimation, and 1.35 beam pitch)
is 1.5 mGy; a quarter of the dose delivered by conven-
tional low-dose CT.
Some researchers (13, 23) have concluded that image
quality and diagnostic accuracy do not deteriorate when
tube currents are reduced within a certain range.
Therefore, in order to reduce the radiation dose and
radiation associated risks, some investigators have used
ultra-low-dose CT protocols. Rusinek et al. (23) compared
200 CT image panels acquired at 20 mAs and 200 mAs
using a four-point confidence scale based on lesion sizes,
locations, and the relationship between the blood vessels
and pulmonary nodules. In this previous study, six
observers compared images acquired at these two currents
(doses), and of 864 positive panels, 259 (60%) of 432 low-
dose panels and 272 (63%) of 432 conventional panels
were correctly interpreted (p = 0.259). Naidich et al. (13)
compared CT scans obtained at 140 mAs and 10 mAs with
all other parameters held constant, and found that at all
thorax levels, visualizations of parenchymal structures
were unaffected by reducing tube currents. However,
these studies used higher tube currents than those used in
the present study.
Other investigators have concluded that ultra-low dose
CT produces unacceptable image qualities. Mayo et al. (24)
found that reducing chest CT radiation dose to 40 mA
degraded image quality and reduced reader diagnostic
accuracy. In the present study, axial images obtained at 16,
8, and 4 mAs also showed increasing noise and poorer
image clarity.
We were curious as to whether the CAD system would
enable us to avoid the limitations associated with low
photon noise and low image contrast caused by reducing
the tube current. Theoretically, quantum noise increases
inversely in proportion to the square root of the amperage.
However, because the lungs are aerated, they generate
more contrast than solid organs, and the detection of
pathological changes in the lung are less dependent on
image noise than for those in solid organs (3).
In the present study, we found no difference in nodule
detection rates using CAD between 32, 16, and 8 mAs.
Therefore, we assert that 8 mAs is the lowest setting that
can be employed without losing pulmonary nodule
detectability using CAD in normal or slim patients.
However, this limitation could be managed using
automatic dose modulation based on an individual BMI.
A limitation of this study is that no histological data on
lung nodules was incorporated into the present study. We
found the nodules in 23 of 25 patients, and this proportion
is unusually higher than that of normal population (35%)
reported previously by Chong et al. (1). Furthermore, the
average of the number of true nodules (3.1 per person)
from 23 patients that had nodules was more than the value
determined (1.8 per person) by Chong et al. We assume
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in our study were not truly a healthy population. Of
course, the subjects were asymptomatic, and most of the
candidates that wanted to be included in this study have a
history of previous disease such as tuberculosis or breast
cancer.
In conclusion, reducing the radiation dose lowers lung
nodule detectability as determined by the use of by CAD.
However, relatively low dose scans were found to be
acceptable using CAD, and in particular, to cause no signif-
icant reduction in nodule detectability in comparison with
usual low-dose CT.
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